Skip Navigation

Cardiovascular Research 2002 55(3):534-543; doi:10.1016/S0008-6363(02)00455-8
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hausenloy, D. J
Right arrow Articles by Yellon, D. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hausenloy, D. J
Right arrow Articles by Yellon, D. M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?

Derek J Hausenloy, Helen L Maddock, Gary F Baxter and Derek M Yellon*

The Hatter Institute for Cardiovascular Studies, Center for Cardiology, University College London Hospitals and Medical School, Grafton Way, London WC1E 6DB, UK

* Corresponding author. Tel.: +44-7380-9776; fax: +44-7388-5095 hatter-institute{at}ucl.ac.uk

Objective: We propose that ischemic preconditioning (IPC) and mitochondrial KATP channel activation protect the myocardium by inhibiting mitochondrial permeability transition pore (MPTP) opening at reperfusion. Methods: Isolated rat hearts were subjected to 35 min ischemia/120 min reperfusion and assigned to the following groups: (1) control; (2) IPC of 2x5 min each of preceding global ischemia; (3,4,5) 0.2 µmol/l cyclosporin A (CsA, which inhibits MPTP opening), 5 µmol/l FK506 (which inhibits the phosphatase calcineurin without inhibiting MPTP opening), or 20 µmol/l atractyloside (Atr, a MPTP opener) given at reperfusion; (6,7) pre-treatment with 30 µmol/l diazoxide (Diaz, a mitochondrial KATP channel opener) or 200 nmol/l 2 chloro-N6-cyclopentyl-adenosine (CCPA, an adenosine A1 receptor agonist); (8) IPC+Atr; (9) Diaz+Atr; (10) CCPA+Atr. The effect of mitochondrial KATP channel activation on calcium-induced MPTP opening in isolated calcein-loaded mitochondria was also assessed. Results: IPC, CsA when given at reperfusion, and pre-treatment with diazoxide or CCPA all limited infarct size (19.9±2.6% in IPC; 24.6±1.9% in CsA, 18.0±1.7% in Diaz, 20.4±3.3% in CCPA vs. 44.7±2.0% in control, P<0.0001). Opening the MPTP with atractyloside at reperfusion abolished this cardio-protective effect (47.7±1.8% in IPC+Atr, 42.3±3.2% in Diaz+Atr, 51.2±1.6% in CCPA+Atr). Atractyloside and FK506, given at reperfusion, did not influence infarct size (45.7±2.1% in Atr and 43.1±3.6% in FK506 vs. 44.7±2.0% in control, P = NS). Diazoxide (30 µmol/l) was shown to reduce calcium-induced MPTP opening by 52.5±8.0% in calcein-loaded mitochondria. 5-Hydroxydecanoic acid (100 µmol/l) was able to abolish the cardio-protective effects of both diazoxide and IPC. Conclusion: One interpretation of these data is that IPC and mitochondrial KATP channel activation may protect the myocardium by inhibiting MPTP opening at reperfusion.

KEYWORDS Ischemia; K-ATP channel; Membrane permeability/physics; Mitochondria; Preconditioning; Reperfusion


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
K. Boengler, R. Schulz, and G. Heusch
Loss of cardioprotection with ageing
Cardiovasc Res, July 15, 2009; 83(2): 247 - 261.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Gomez, B. Li, N. Mewton, I. Sanchez, C. Piot, M. Elbaz, and M. Ovize
Inhibition of mitochondrial permeability transition pore opening: translation to patients
Cardiovasc Res, July 15, 2009; 83(2): 226 - 233.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Juhaszova, D. B. Zorov, Y. Yaniv, H. B. Nuss, S. Wang, and S. J. Sollott
Role of Glycogen Synthase Kinase-3{beta} in Cardioprotection
Circ. Res., June 5, 2009; 104(11): 1240 - 1252.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Saotome, H. Katoh, Y. Yaguchi, T. Tanaka, T. Urushida, H. Satoh, and H. Hayashi
Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1125 - H1132.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
J. Huffmyer and J. Raphael
Physiology and Pharmacology of Myocardial Preconditioning and Postconditioning
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2009; 13(1): 5 - 18.
[Abstract] [PDF]


Home page
Anesth. Analg.Home page
Y. Mio, Y. H. Shim, E. Richards, Z. J. Bosnjak, P. S. Pagel, and M. Bienengraeber
Xenon Preconditioning: The Role of Prosurvival Signaling, Mitochondrial Permeability Transition and Bioenergetics in Rats
Anesth. Analg., March 1, 2009; 108(3): 858 - 866.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Ananthakrishnan, M. Kaneko, Y. C. Hwang, N. Quadri, T. Gomez, Q. Li, C. Caspersen, and R. Ramasamy
Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore
Am J Physiol Heart Circ Physiol, February 1, 2009; 296(2): H333 - H341.
[Abstract] [Full Text] [PDF]


Home page
Alcohol AlcoholHome page
K. Zhou, L. Zhang, J. Xi, W. Tian, and Z. Xu
Ethanol Prevents Oxidant-Induced Mitochondrial Permeability Transition Pore Opening in Cardiac Cells
Alcohol Alcohol., January 1, 2009; 44(1): 20 - 24.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. B. West, G. Rokosh, D. Obal, M. Velayutham, Y.-T. Xuan, B. G. Hill, R. J. Keith, J. Schrader, Y. Guo, D. J. Conklin, et al.
Cardiac Myocyte-Specific Expression of Inducible Nitric Oxide Synthase Protects Against Ischemia/Reperfusion Injury by Preventing Mitochondrial Permeability Transition
Circulation, November 4, 2008; 118(19): 1970 - 1978.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. G. Leshnower, S. Kanemoto, M. Matsubara, H. Sakamoto, R. Hinmon, J. H. Gorman III, and R. C. Gorman
Cyclosporine Preserves Mitochondrial Morphology After Myocardial Ischemia/Reperfusion Independent of Calcineurin Inhibition
Ann. Thorac. Surg., October 1, 2008; 86(4): 1286 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Ban, A. J. Cooper, S. Samuel, A. Bhatti, M. Patel, S. Izumo, J. M. Penninger, P. H. Backx, G. Y. Oudit, and R. G. Tsushima
Phosphatidylinositol 3-Kinase {gamma} Is a Critical Mediator of Myocardial Ischemic and Adenosine-Mediated Preconditioning
Circ. Res., September 12, 2008; 103(6): 643 - 653.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Chanoit, S. Lee, J. Xi, M. Zhu, R. A. McIntosh, R. A. Mueller, E. A. Norfleet, and Z. Xu
Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3{beta}
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1227 - H1233.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. E. McAllister, H. Ashrafpour, N. Cahoon, N. Huang, M. A. Moses, P. C. Neligan, C. R. Forrest, J. E. Lipa, and C. Y. Pang
Postconditioning for salvage of ischemic skeletal muscle from reperfusion injury: efficacy and mechanism
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R681 - R689.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Nishino, I. G. Webb, S. M. Davidson, A. I. Ahmed, J. E. Clark, S. Jacquet, A. M. Shah, T. Miura, D. M. Yellon, M. Avkiran, et al.
Glycogen Synthase Kinase-3 Inactivation Is Not Required for Ischemic Preconditioning or Postconditioning in the Mouse
Circ. Res., August 1, 2008; 103(3): 307 - 314.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Piot, P. Croisille, P. Staat, H. Thibault, G. Rioufol, N. Mewton, R. Elbelghiti, T. T. Cung, E. Bonnefoy, D. Angoulvant, et al.
Effect of Cyclosporine on Reperfusion Injury in Acute Myocardial Infarction
N. Engl. J. Med., July 31, 2008; 359(5): 473 - 481.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. J. Clarke, I. Khaliulin, M. Das, J. E. Parker, K. J. Heesom, and A. P. Halestrap
Inhibition of Mitochondrial Permeability Transition Pore Opening by Ischemic Preconditioning Is Probably Mediated by Reduction of Oxidative Stress Rather Than Mitochondrial Protein Phosphorylation
Circ. Res., May 9, 2008; 102(9): 1082 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
R. Huhn, A. Heinen, N. C. Weber, M. W. Hollmann, W. Schlack, and B. Preckel
Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore
Br. J. Anaesth., April 1, 2008; 100(4): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. A Javadov, S. Clarke, M. Das, E. J Griffiths, K. H H Lim, and A. P Halestrap
Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart
J. Physiol., June 1, 2003; 549(2): 513 - 524.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.